In the latest trading session, Organon (OGN) closed at $9.28, marking a -1.07% move from the previous day.
Organon remains a buy as the stock trades at distressed valuations despite stable fundamentals and progress on debt reduction. OGN's Women's Health and Biosimilars segments drive growth, offsetting re
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that it has signed a purchase and sale agreement (
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) reached $10.84 at the closing of the latest trading day, reflecting a -1.54% change compared to its last close.
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Organon (OGN) reached $10.35 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
Organon (OGN) closed the most recent trading day at $10.12, moving 2.79% from the previous trading session.
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
VANCOUVER, BC / ACCESS Newswire / September 24, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage
In the closing of the recent trading day, Organon (OGN) stood at $10.45, denoting a -3.69% move from the preceding trading day.
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--European Commission Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars.
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Organon (OGN) concluded the recent trading session at $10.26, signifying a -1.06% move from its prior day's close.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE